Clincosm LogoSign in Get a demo

recurrent head and neck squamous cell carcinoma

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

Not yet recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Ficlatuzumab
  • +2 more
  • (no location specified)
Sep 26, 2023

Recurrent Head Neck Cancer, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Carcinoma Trial in Saint

Not yet recruiting
  • Recurrent Head and Neck Cancer
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 30, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (drug, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jul 13, 2023

Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Nashville (biological, other,

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Panitumumab
  • +9 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Jun 4, 2023

Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • RP3
  • +3 more
  • (no location specified)
Feb 21, 2023

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Resectable Head and Neck Squamous Cell Carcinoma Trial in Boston

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Feb 11, 2023

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +21 more
  • Atezolizumab
  • +8 more
  • Little Rock, Arkansas
  • +97 more
Jan 27, 2023

Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +3 more
  • 200 mg Pembrolizumab
  • +2 more
  • Miami, Florida
  • +6 more
Jan 9, 2023

Recurrent Head and Neck Squamous Cell Carcinoma Trial in Atlanta, Cleveland, Milwaukee (IMRT, Nivolumab)

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • IMRT
  • Nivolumab
  • Atlanta, Georgia
  • +3 more
Jan 10, 2023

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Houston (other,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Boston (Interleukin-15

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Interleukin-15 Superagonist (N-803)
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 2, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

Terminated
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +2 more
  • ImmunoPulse
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Sep 1, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +107 more
Aug 24, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma Trial in

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +14 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Indianapolis, Indiana
  • +4 more
Aug 19, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Head Neck Cancer Stage IV Trial in Spain (Nivolumab + Paclitaxel, Cetuximab +

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Head and Neck Cancer Stage IV
  • Nivolumab + Paclitaxel
  • Cetuximab + Paclitaxel
  • Santander, Cantabria, Spain
  • +20 more
Aug 2, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Efineptakin alfa
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Squamous Cell Carcinoma of the Hypopharynx, Metastatic Squamous

Active, not recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 27, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Unresectable Head and Neck

Active, not recruiting
Has Results
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Cetuximab
  • +2 more
  • Washington, District of Columbia
  • +1 more
Mar 25, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial in Seattle (biological,

Terminated
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Durvalumab
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Feb 23, 2022

Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck

Recruiting
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Pembrolizumab (immunotherapy)
  • Quad-shot palliative radiotherapy
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Feb 7, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Dec 5, 2021

Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma Trial in Saint Louis

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 6, 2021